Patents by Inventor Heinz Uragg

Heinz Uragg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulations comprising N,N?-disubstituted piperazine compounds
    Patent number: 7816358
    Abstract: Pharmaceutical formulations comprising N,N?disubstituted piperazine compounds and related methods of treatment using these formulations.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: October 19, 2010
    Assignee: Gruenenthal GmbH
    Inventors: Heinz Uragg, Corinna Maul, Helmut Buschmann, Bernd Sundermann, Michael Haubrand, Boris Chizh
  • Sulfonylguanidine compounds and pharmaceutical uses thereof
    Patent number: 7671074
    Abstract: Sulfonylguanidine compounds corresponding to the tautomeric formulas I and Ia, a method for producing them, pharmaceutical compositions containing them, and methods of using them to prepare medicaments and for treating various medical conditions. The sulfonylguanidine compounds have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
    Type: Grant
    Filed: May 1, 2007
    Date of Patent: March 2, 2010
    Assignee: Gruenenthal GmbH
    Inventors: Matthias Gerlach, Heinz Uragg, Michael Haurand, Claudia Katharina Puetz, Corinna Sundermann, Boris Chizh
  • 1, 5-diaminopentan-3-ol compounds and related treatment methods
    Patent number: 7569585
    Abstract: Substituted 1,5-diaminopentan-3-ol compounds and methods of making the same. Pharmaceutical compositions containing these compounds and methods of treatment using these pharmaceutical compositions.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: August 4, 2009
    Assignee: Gruenenthal GmbH
    Inventors: Heinz Uragg, Corinna Maul, Helmut Buschmann, Bernd Sundermann, Werner Englberger
  • Pharmaceutical preparations comprising substituted beta-aminoalcohols
    Patent number: 7507816
    Abstract: Pharmaceutical compositions containing substituted aminoalcohols, the use of preparations containing substituted aminoalcohols for treatment of conditions such as pain, emesis, neurotropic conditions, cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol or drug dependency, inflammation, depression, decreased vigilance, or depressed libido, as well as 2-(aminomethyl)cycloalkane-1-ol compounds and a process for their preparation.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: March 24, 2009
    Assignee: Gruenenthal GmbH
    Inventors: Heinz Uragg, Corinna Maul, Helmut Buschmann, Bernd Sundermann, Hagen-Heinrich Hennies
  • N, N'-disubstituted piperazine compounds and their use as analgesics
    Patent number: 7390812
    Abstract: N,N?-disubstituted piperazine compounds, processes for the production thereof, and pharmaceutical preparations containing these compounds. The use of N,N?-disubstituted piperazine compounds for the production of pharmaceutical preparations and in related methods of treatment.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: June 24, 2008
    Assignee: Gruenenthal GmbH
    Inventors: Heinz Uragg, Corinne Maul, Helmut Buschmann, Bernd Sundermann, Hagen-Heinrich Hennies
  • SULFONYLGUANIDINE COMPOUNDS AND PHARMACEUTICAL USES THEREOF
    Publication number: 20080085900
    Abstract: Sulfonylguanidine compounds corresponding to the tautomeric formulas I and Ia, a method for producing them, pharmaceutical compositions containing them, and methods of using them to prepare medicaments and for treating various medical conditions. The sulfonylguanidine compounds have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
    Type: Application
    Filed: May 1, 2007
    Publication date: April 10, 2008
    Applicant: GRUENENTHAL GmbH
    Inventors: MATTHIAS GERLACH, Heinz Uragg, Michael Haurand, Claudia Puetz, Corinna Sundermann, Boris Chizh
  • Pharmaceutical formulations comprising N,N'-disubstituted piperazine compounds
    Publication number: 20050038034
    Abstract: Pharmaceutical formulations comprising N,N?disubstituted piperazine compounds and related methods of treatment using these formulations.
    Type: Application
    Filed: June 14, 2004
    Publication date: February 17, 2005
    Applicant: Grunenthal GmbH
    Inventors: Heinz Uragg, Corinna Maul, Helmut Buschmann, Bernd Sundermann, Michael Haurand, Boris Chizh
  • N, N'-disubstituted piperazine compounds and their use as analgesics
    Publication number: 20050026926
    Abstract: N,N?-disubstituted piperazine compounds, processes for the production thereof, and pharmaceutical preparations containing these compounds. The use of N,N?-disubstituted piperazine compounds for the production of pharmaceutical preparations and in related methods of treatment.
    Type: Application
    Filed: June 14, 2004
    Publication date: February 3, 2005
    Applicant: Gruenenthal GmbH
    Inventors: Heinz Uragg, Corinne Maul, Helmut Buschmann, Bernd Sundermann, Hagen-Heinrich Hennies
  • Pharmaceutical preparations comprising substituted beta-aminoalcohols
    Publication number: 20050020691
    Abstract: Pharmaceutical compositions containing substituted aminoalcohols, the use of preparations containing substituted aminoalcohols for treatment of conditions such as pain, emesis, neurotropic conditions, cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol or drug dependency, inflammation, depression, decreased vigilance, or depressed libido, as well as 2-(aminomethyl)cycloalkane-1-ol compounds and a process for their preparation.
    Type: Application
    Filed: June 14, 2004
    Publication date: January 27, 2005
    Applicant: Gruenenthal GmbH
    Inventors: Heinz Uragg, Corinna Maul, Helmut Buschmann, Bernd Sundermann, Hagen-Heinrich Hennies
  • 1, 5-diaminopentan-3-ol compounds and related treatment methods
    Publication number: 20050020562
    Abstract: Substituted 1,5-diaminopentan-3-ol compounds and methods of making the same. Pharmaceutical compositions containing these compounds and methods of treatment using these pharmaceutical compositions.
    Type: Application
    Filed: June 14, 2004
    Publication date: January 27, 2005
    Applicant: GRUENENTHAL GMBH
    Inventors: Heinz Uragg, Corinna Maul, Helmut Buschmann, Bernd Sundermann, Werner Englberger
  • Sulfonylguanidine compounds and pharmaceutical uses thereof
    Publication number: 20030225084
    Abstract: Sulfonylguanidine compounds corresponding to the tautomeric formulas I and Ia, a method for producing them, pharmaceutical compositions containing them, and methods of using them to prepare medicaments and for treating various medical conditions. The sulfonylguanidine compounds have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
    Type: Application
    Filed: March 31, 2003
    Publication date: December 4, 2003
    Applicant: Gruenenthal GmbH
    Inventors: Matthias Gerlach, Heinz Uragg, Michael Haurand, Claudia Katharina Puetz, Corinna Maul, Boris Chizh